AltRx advertises self-pay weight management with compounded GLP-1 and GLP-1/GIP options as well as branded medicine entries. Its current homepage uses promotional rates and claims to simplify access and pricing.

For comparison, the important details are the selected prescription and membership terms. Several rate references on the page mean a reader should confirm the final offer rather than assume the lowest number applies to every pathway.

Offer highlights

  • Compounded and branded menu described
  • Provider review before prescribing
  • Public explanation of care and fulfillment

Ask before paying

  • Does the displayed rate apply to renewals?
  • What preparation is in my prescription?
  • Which pharmacy and practice provide care?

Products, pricing & billing

The live homepage advertised compounded GLP-1 from $89 and GLP-1/GIP from $149 during research, while another cost table used a different figure for the second option. Treat these as promotional information and request the price and term in writing.

Confirm whether the quoted total includes the medical review, prescription fulfillment, supplies, and delivery. Ask whether a promotional deadline affects only the first purchase or later renewals.

Care and follow-up

AltRx describes consultation by a provider licensed in the patient’s state, with format guided by clinical needs and state rules. Its public disclosures identify independent medical practices and partner compounding pharmacies.

The company’s self-reported results are not randomized trials of its formulations. The clinician should determine suitability independently of the marketing questionnaire.

Our take

AltRx is a useful self-pay price comparison if its final offer is clear. We would compare the complete recurring rate, pharmacy details, and follow-up terms with CoreAge and LevelsRx. Lower promotional pricing does not itself establish a better clinical outcome.

Put the offer in context

Read the GLP-1 program comparison and complete cost guide to compare membership, medication, and recurring charges. The branded and compounded treatment guide explains the product distinctions.

Our CoreAge Rx review describes its advertised medicine-inclusive monthly offer and refund deadlines.

Sources & offer details

Public information retrieved on October 1, 2026. Provider statements describe the advertised offer; they do not independently establish treatment outcomes.

  1. AltRx: Official program and offer information ↗
  2. FDA: Concerns with unapproved GLP-1 drugs ↗